Table 4.
Cancer | Gene | Population | Previous Reports | Identified Variant (GRCh38) |
REVEL Score 1 |
Clinvar 2 | |
---|---|---|---|---|---|---|---|
Same Population | Other Population | ||||||
BRCA | BAP1 | White | Shahriyari et al. (2019) | 3:52442072-T/C | 0.829 | pathogenic | |
African American/Black | |||||||
BLM | White | Cybulski et al. (2019) | 15:91312388-C/T | 0.677 | uncertain significance | ||
African American/Black | |||||||
OV | ERCC5 | White | Doherty et al. (2011) | 3:103525633-G/T | 0.939 | pathogenic | |
African American/Black | Doherty et al. (2011) | ||||||
STAD | ATM | White | Helgason et al. (2015) | 11:108141997-C/T | 0.739 | uncertain significance | |
Asian | Cai et al. (2015) | ||||||
MSH6 | White | Karpińska-Kaczmarczyk et al. (2016) | 2:48028049-G/A | 0.857 | uncertain significance | ||
Asian | |||||||
PTEN | African American/Black | Nemtsova et al. (2020) | 10:89692905-G/A | 0.976 | likely pathogenic, pathogenic |
1 REVEL scores above 0.5 represent likely disease-causing variants. 2 Five levels of variants defined in ClinVar database are as follows: pathogenic, likely pathogenic, uncertain significance, likely benign, and benign.